- Home
- CMBM vs HOTH Comparison
CMBM vs HOTH Comparison
Compare CMBM & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMBM
- HOTH
- Stock Information
- Founded
- CMBM 2011
- HOTH 2017
- Country
- CMBM United States
- HOTH United States
- Employees
- CMBM N/A
- HOTH N/A
- Industry
- CMBM Radio And Television Broadcasting And Communications Equipment
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- CMBM Technology
- HOTH Health Care
- Exchange
- CMBM Nasdaq
- HOTH Nasdaq
- Market Cap
- CMBM 17.7M
- HOTH 18.0M
- IPO Year
- CMBM 2019
- HOTH 2019
- Fundamental
- Price
- CMBM $2.28
- HOTH $1.27
- Analyst Decision
- CMBM Buy
- HOTH Strong Buy
- Analyst Count
- CMBM 1
- HOTH 2
- Target Price
- CMBM $3.00
- HOTH $4.50
- AVG Volume (30 Days)
- CMBM 43.3M
- HOTH 553.1K
- Earning Date
- CMBM 11-06-2025
- HOTH 11-11-2025
- Dividend Yield
- CMBM N/A
- HOTH N/A
- EPS Growth
- CMBM N/A
- HOTH N/A
- EPS
- CMBM N/A
- HOTH N/A
- Revenue
- CMBM $172,215,000.00
- HOTH N/A
- Revenue This Year
- CMBM N/A
- HOTH N/A
- Revenue Next Year
- CMBM $18.01
- HOTH N/A
- P/E Ratio
- CMBM N/A
- HOTH N/A
- Revenue Growth
- CMBM N/A
- HOTH N/A
- 52 Week Low
- CMBM $0.23
- HOTH $0.66
- 52 Week High
- CMBM $6.80
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- CMBM 55.93
- HOTH 36.67
- Support Level
- CMBM $2.04
- HOTH $1.18
- Resistance Level
- CMBM $2.92
- HOTH $1.43
- Average True Range (ATR)
- CMBM 0.86
- HOTH 0.07
- MACD
- CMBM 0.04
- HOTH -0.01
- Stochastic Oscillator
- CMBM 27.18
- HOTH 29.29
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).